NCT02688049

NeuroRegen Scaffold™ Combined With Stem Cells for Chronic Spinal Cord Injury Repair

The Efficacy and Safety of NeuroRegen Scaffold™ Combined With Mesenchymal Stem Cells or Neural Stem Cells for Chronic Spinal Cord Injury Repair

• Status: Unknown
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: Chinese Academy of Sciences · Other Government
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess the efficacy and safety of mesenchymal stem cells or neural stem cells combined with NeuroRegen scaffold transplantation in patients with spinal cord injury.

Conditions

• Spinal Cord Injury

Interventions

Type	Name	Description
BIOLOGICAL	NeuroRegen scaffold/mesenchymal stem cells transplantation	Patients with chronic SCI (ASIA grade A) will receive NeuroRegen Scaffold with 10 million mesenchymal stem cells transplantation after localized scars cleared and after surgery patients will undergo a comprehensive rehabilitation, psychological and nutritional measures.
BIOLOGICAL	NeuroRegen scaffold/neural stem cells transplantation	Patients with chronic SCI (ASIA grade A) will receive NeuroRegen Scaffold with 10 million neural stem cells transplantation after localized scars cleared and after surgery patients will undergo a comprehensive rehabilitation, psychological and nutritional measures.

Timeline

• Start date: 2016-01-01
• Primary completion: 2021-12-01
• Completion: 2021-12-01
• First posted: 2016-02-23
• Last updated: 2020-12-23

Locations

1 site across 1 country: China